242 related articles for article (PubMed ID: 27540978)
1. Single nucleotide polymorphism of hsa-miR-124a affects risk and prognosis of osteosarcoma.
Shi ZW; Wang JL; Zhao N; Guan Y; He W
Cancer Biomark; 2016 Jun; 17(2):249-57. PubMed ID: 27540978
[TBL] [Abstract][Full Text] [Related]
2. Pri-miR-124 rs531564 polymorphism and colorectal cancer risk.
Gao XR; Wang HP; Zhang SL; Wang MX; Zhu ZS
Sci Rep; 2015 Oct; 5():14818. PubMed ID: 26423518
[TBL] [Abstract][Full Text] [Related]
3. Association of GRM4 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma in Guangxi Chinese population.
Wang K; Zhao J; He M; Fowdur M; Jiang T; Luo S
Tumour Biol; 2016 Jan; 37(1):1105-12. PubMed ID: 26276359
[TBL] [Abstract][Full Text] [Related]
4. Genetic variations in interleukin-6 polymorphism and the association with susceptibility and overall survival of osteosarcoma.
Qi Y; Zhao C; Li H; Zhang B; Tada K; Abe H; Tada M
Tumour Biol; 2016 Jul; 37(7):9807-11. PubMed ID: 26810186
[TBL] [Abstract][Full Text] [Related]
5. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
Li Q; Song S; Ni G; Li Y; Wang X
Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
[TBL] [Abstract][Full Text] [Related]
6. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
Liu W; Zhao ZY; Shi L; Yuan WD
Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
[TBL] [Abstract][Full Text] [Related]
7. [Correlation analysis between miR-124 rs531564 polymorphisms and susceptibility to cervical cancer].
Xiong X; Cheng J; Liu X; Tang S; Luo X
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):210-3. PubMed ID: 24589598
[TBL] [Abstract][Full Text] [Related]
8. MiR-608, pre-miR-124-1 and pre-miR26a-1 polymorphisms modify susceptibility and recurrence-free survival in surgically resected CRC individuals.
Ying HQ; Peng HX; He BS; Pan YQ; Wang F; Sun HL; Liu X; Chen J; Lin K; Wang SK
Oncotarget; 2016 Nov; 7(46):75865-75873. PubMed ID: 27713147
[TBL] [Abstract][Full Text] [Related]
9. A miR-146a polymorphism (rs2910164) predicts risk of and survival from colorectal cancer.
Chae YS; Kim JG; Lee SJ; Kang BW; Lee YJ; Park JY; Jeon HS; Park JS; Choi GS
Anticancer Res; 2013 Aug; 33(8):3233-9. PubMed ID: 23898084
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
[TBL] [Abstract][Full Text] [Related]
11. A Genetic Variant in miR-124 Decreased the Susceptibility to Esophageal Squamous Cell Carcinoma in a Chinese Kazakh Population.
Wu F; Li M; You W; Ji Y; Cui X; Hu J; Chen Y; Pang L; Li S; Wei Y; Yang L; Li F
Genet Test Mol Biomarkers; 2018 Jan; 22(1):29-34. PubMed ID: 29227754
[TBL] [Abstract][Full Text] [Related]
12. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
[TBL] [Abstract][Full Text] [Related]
13. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
Wang Z; Cai H; Lin L; Tang M; Cai H
Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.
Wang G; Shen N; Cheng L; Lin J; Li K
Tumour Biol; 2015 Sep; 36(10):7891-5. PubMed ID: 25953260
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 10 gene -1082A/G polymorphism is associated with osteosarcoma risk and poor outcomes in the Chinese population.
Cui Y; Zhu JJ; Ma CB; Cui K; Wang F; Ni SH; Zhang ZY
Tumour Biol; 2016 Apr; 37(4):4517-22. PubMed ID: 26503210
[TBL] [Abstract][Full Text] [Related]
16. miR-21 predicts poor prognosis in patients with osteosarcoma.
Ren X; Shen Y; Zheng S; Liu J; Jiang X
Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
[TBL] [Abstract][Full Text] [Related]
17. Correlation between TGF-β1 gene 29 T > C single nucleotide polymorphism and clinicopathological characteristics of osteosarcoma.
Wu Y; Zhao J; He M
Tumour Biol; 2015 Jul; 36(7):5149-56. PubMed ID: 25663491
[TBL] [Abstract][Full Text] [Related]
18. Association of the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and survival in the Korean population.
Ahn DH; Rah H; Choi YK; Jeon YJ; Min KT; Kwack K; Hong SP; Hwang SG; Kim NK
Mol Carcinog; 2013 Nov; 52 Suppl 1():E39-51. PubMed ID: 23001871
[TBL] [Abstract][Full Text] [Related]
19. A causal role for circulating miR-34b in osteosarcoma.
Tian Q; Jia J; Ling S; Liu Y; Yang S; Shao Z
Eur J Surg Oncol; 2014 Jan; 40(1):67-72. PubMed ID: 24063968
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA MTO1 intercorrelates with microRNA-630, both associate with Enneking stage and/or pathological fracture as well as prognosis in osteosarcoma patients.
Shi Z; Wen Y; Zhang S; Cheng X
J Clin Lab Anal; 2021 Nov; 35(11):e23987. PubMed ID: 34545623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
